Acutus Medical, Inc.

AFIB Healthcare Medical Devices

In the quarter to December 2024, revenue grew 204.2%, EPS grew 95.9% and free cash flow grew 76.4%, each against the same quarter a year earlier. Revenue growth for three consecutive years, operating cash flow growth for three.

0.00 0.00 NaN
Market cap
$1.7M
P/E
0.0×
Fwd P/E
−0.5×
Dividend yield
—
F-score
3/9
Altman Z
−28.52
Beneish M
−2.49
Dividend safety
n/a
Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24
Piotroski F-Score
— — — 6 4 3 3 3
P/E ratio
— 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/S ratio
— 4.73 4.73 38.83 5.66 13.06 0.85 0.09
Altman Z-Score
— — — (0.35) (4.35) (3.18) (15.48) (28.51)
Altman Z″-Score (non-manufacturers)
— (31.23) (9.12) (2.87) (7.73) (4.43) (34.40) (66.67)
P/FCF ratio
— 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/Operating CF
— (1.11) (1.11) (13.62) (4.33) (2.35) (0.34) (0.44)
Beneish M-Score
— — — — — — — (2.49)
P/B ratio
— 0.00 0.00 2.60 0.92 0.53 0.00 0.00
EV/Sales
— 7.20 7.20 28.05 2.18 (0.62) 1.56 1.01
EV/EBITDA
— 0.00 0.00 0.00 0.00 0.00 0.00 10.86
EV/FCF
— (0.38) (0.38) (2.46) (0.34) 0.02 (0.18) (0.64)
Current Ratio
— 0.88 2.58 6.91 6.82 5.93 2.44 2.06
Net Debt/EBITDA
— (0.25) 0.63 1.06 0.59 (0.75) (0.43) 9.90
Debt/Equity
— (1.92) 1.42 0.32 0.39 0.46 (39.27) (2.81)
ROE
— 26.79% 54.27% 205.55% (101.32%) (43.84%) (220.29%) 153.11%
ROA
— (369.25%) (147.70%) (68.45%) (64.96%) (26.13%) (87.15%) (23.11%)
ROIC
— 0.00% 0.00% (161.69%) (153.63%) 76.43% (174.27%) (0.51%)
Return on Tangible Assets
— (4,795.50%) (176.52%) (71.90%) (96.90%) (39.75%) (290.25%) (69.91%)
Average Days of Receivables
— 27.64 33.85 93.15 76.81 2,157.85 578.43 142.65
Earnings Yield
— (507.09%) (507.09%) (211.93%) (120.82%) (104.32%) (1,335.95%) (545.33%)
Free Cash Flow Yield
— (399.86%) (399.86%) (29.33%) (112.22%) (225.26%) (1,036.62%) (1,778.87%)
Free Cash Flow per Share
— (65.62) (103.25) (8.45) (3.83) (3.13) (2.18) (1.07)
Book value per Share
— (24.74) 40.99 11.10 3.69 2.63 (0.03) (0.39)
Free Cash Flow
— (35.82) (69.38) (96.39) (109.65) (89.14) (63.34) (31.77)
EV/EBIT
— 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other line items

Show all line items

Columns are period end dates